260 related articles for article (PubMed ID: 29514145)
21. Midregional pro-adrenomedullin as a predictor for therapeutic response to midodrine hydrochloride in children with postural orthostatic tachycardia syndrome.
Zhang F; Li X; Ochs T; Chen L; Liao Y; Tang C; Jin H; Du J
J Am Coll Cardiol; 2012 Jul; 60(4):315-20. PubMed ID: 22813609
[TBL] [Abstract][Full Text] [Related]
22. High Level of Mid-Regional Proadrenomedullin during ST-Segment Elevation Myocardial Infarction Is an Independent Predictor of Adverse Cardiac Events within 90-Day Follow-Up.
Hartopo AB; Puspitawati I; Anggraeni VY
Medicina (Kaunas); 2022 Jun; 58(7):. PubMed ID: 35888580
[TBL] [Abstract][Full Text] [Related]
23. MR-proANP and MR-proADM for risk stratification of patients with acute chest pain.
Tzikas S; Keller T; Ojeda FM; Zeller T; Wild PS; Lubos E; Kunde J; Baldus S; Bickel C; Lackner KJ; Münzel TF; Blankenberg S
Heart; 2013 Mar; 99(6):388-95. PubMed ID: 23213173
[TBL] [Abstract][Full Text] [Related]
24. Thirty and ninety days mortality predictive value of admission and in-hospital procalcitonin and mid-regional pro-adrenomedullin testing in patients with dyspnea. Results from the VERyfing DYspnea trial.
Travaglino F; Russo V; De Berardinis B; Numeroso F; Catania P; Cervellin G; Nigra SG; Geraci F; Bressan MA; Guerrini S; Cavazza M; Folli C; Monzani V; Battista S; Mengozzi G; Noto P; Carpinteri G; Semplicini A; Stella F; Ingrassia S; Moscatelli P; Giuntini P; Salerno G; Cardelli P; Di Somma S
Am J Emerg Med; 2014 Apr; 32(4):334-41. PubMed ID: 24559907
[TBL] [Abstract][Full Text] [Related]
25. Stress markers predict mortality in patients with nonspecific complaints presenting to the emergency department and may be a useful risk stratification tool to support disposition planning.
Nickel CH; Messmer AS; Geigy N; Misch F; Mueller B; Dusemund F; Hertel S; Hartmann O; Giersdorf S; Bingisser R
Acad Emerg Med; 2013 Jul; 20(7):670-9. PubMed ID: 23859580
[TBL] [Abstract][Full Text] [Related]
26. Utility of 14 novel biomarkers in patients with acute chest pain and undetectable levels of conventional cardiac troponin.
Meune C; Balmelli C; Twerenbold R; Reiter M; Reichlin T; Ziller R; Drexler B; Stelzig C; Freese M; Wolf C; Haaf P; Osswald S; Mueller C
Int J Cardiol; 2013 Aug; 167(4):1164-9. PubMed ID: 22507551
[TBL] [Abstract][Full Text] [Related]
27. Perioperative Myocardial Injury After Noncardiac Surgery: Incidence, Mortality, and Characterization.
Puelacher C; Lurati Buse G; Seeberger D; Sazgary L; Marbot S; Lampart A; Espinola J; Kindler C; Hammerer A; Seeberger E; Strebel I; Wildi K; Twerenbold R; du Fay de Lavallaz J; Steiner L; Gurke L; Breidthardt T; Rentsch K; Buser A; Gualandro DM; Osswald S; Mueller C;
Circulation; 2018 Mar; 137(12):1221-1232. PubMed ID: 29203498
[TBL] [Abstract][Full Text] [Related]
28. Associations of mid-regional pro-adrenomedullin levels to cardiovascular and metabolic abnormalities, and mortality in an elderly population from the community.
Eggers KM; Venge P; Lindahl B; Lind L
Int J Cardiol; 2013 Oct; 168(4):3537-42. PubMed ID: 23722054
[TBL] [Abstract][Full Text] [Related]
29. Pro-A-type natriuretic peptide, proadrenomedullin, and N-terminal pro-B-type natriuretic peptide used in a multimarker strategy in primary health care in risk assessment of patients with symptoms of heart failure.
Alehagen U; Dahlström U; Rehfeld JF; Goetze JP
J Card Fail; 2013 Jan; 19(1):31-9. PubMed ID: 23273592
[TBL] [Abstract][Full Text] [Related]
30. Incremental Value of Preoperative Copeptin for Predicting Myocardial Injury.
Mauermann E; Bolliger D; Seeberger E; Puelacher C; Corbiere S; Filipovic M; Seeberger M; Mueller C; Lurati Buse G
Anesth Analg; 2016 Dec; 123(6):1363-1371. PubMed ID: 27870734
[TBL] [Abstract][Full Text] [Related]
31. Midregional fragment of proadrenomedullin, new-onset albuminuria, and cardiovascular and all-cause mortality in patients with type 2 diabetes (ZODIAC-30).
Landman GW; van Dijk PR; Drion I; van Hateren KJ; Struck J; Groenier KH; Gans RO; Bilo HJ; Bakker SJ; Kleefstra N
Diabetes Care; 2014; 37(3):839-45. PubMed ID: 24170764
[TBL] [Abstract][Full Text] [Related]
32. Midregional-proAtrial Natriuretic Peptide and High Sensitive Troponin T Strongly Predict Adverse Outcome in Patients Undergoing Percutaneous Repair of Mitral Valve Regurgitation.
Wöhrle J; Karakas M; Trepte U; Seeger J; Gonska B; Koenig W; Rottbauer W
PLoS One; 2015; 10(9):e0137464. PubMed ID: 26368980
[TBL] [Abstract][Full Text] [Related]
33. Mid-regional pro-adrenomedullin and lactate levels for risk stratification in patients with out-of-hospital cardiac arrest.
Zelniker TA; Schwall D; Hamidi F; Steinbach S; Scheller P; Spaich S; Michels G; Giannitsis E; Katus HA; Frey N; Preusch MR
Eur Heart J Acute Cardiovasc Care; 2023 Jun; 12(6):364-371. PubMed ID: 36943296
[TBL] [Abstract][Full Text] [Related]
34. Mid-region pro-adrenomedullin adds predictive value to clinical predictors and Framingham risk score for long-term mortality in stable outpatients with heart failure.
Xue Y; Taub P; Iqbal N; Fard A; Clopton P; Maisel A
Eur J Heart Fail; 2013 Dec; 15(12):1343-9. PubMed ID: 23887059
[TBL] [Abstract][Full Text] [Related]
35. Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay.
Morgenthaler NG; Struck J; Alonso C; Bergmann A
Clin Chem; 2005 Oct; 51(10):1823-9. PubMed ID: 16099941
[TBL] [Abstract][Full Text] [Related]
36. Can mid-regional pro-adrenomedullin (MR-proADM) increase the prognostic accuracy of NEWS in predicting deterioration in patients admitted to hospital with mild to moderately severe illness? A prospective single-centre observational study.
Graziadio S; O'Leary RA; Stocken DD; Power M; Allen AJ; Simpson AJ; Price DA
BMJ Open; 2019 Feb; 8(11):e020337. PubMed ID: 30798282
[TBL] [Abstract][Full Text] [Related]
37. Association of MR-proadrenomedullin with cardiovascular risk factors and subclinical cardiovascular disease.
Neumann JT; Tzikas S; Funke-Kaiser A; Wilde S; Appelbaum S; Keller T; Ojeda-Echevarria F; Zeller T; Zwiener I; Sinning CR; Jagodzinski A; Schnabel RB; Lackner KJ; Münzel T; Blankenberg S; Wild PS; Sydow K
Atherosclerosis; 2013 Jun; 228(2):451-9. PubMed ID: 23562132
[TBL] [Abstract][Full Text] [Related]
38. Midregional proadrenomedullin (MR-proADM) is a powerful predictor of early death in AL amyloidosis.
Palladini G; Barassi A; Perlini S; Milani P; Foli A; Russo P; Albertini R; Obici L; Lavatelli F; Sarais G; Casarini S; Moratti R; Melzi d'Eril GV; Merlini G
Amyloid; 2011 Dec; 18(4):216-21. PubMed ID: 22070520
[TBL] [Abstract][Full Text] [Related]
39. Usefulness of midregional proadrenomedullin to predict poor outcome in patients with community acquired pneumonia.
Gordo-Remartínez S; Calderón-Moreno M; Fernández-Herranz J; Castuera-Gil A; Gallego-Alonso-Colmenares M; Puertas-López C; Nuevo-González JA; Sánchez-Sendín D; García-Gámiz M; Sevillano-Fernández JA; Álvarez-Sala LA; Andueza-Lillo JA; de Miguel-Yanes JM
PLoS One; 2015; 10(6):e0125212. PubMed ID: 26030588
[TBL] [Abstract][Full Text] [Related]
40. Midregional pro-adrenomedullin plasma concentrations are blunted in severe preeclampsia.
Matson BC; Corty RW; Karpinich NO; Murtha AP; Valdar W; Grotegut CA; Caron KM
Placenta; 2014 Sep; 35(9):780-3. PubMed ID: 25043691
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
